PG

Paul Grayson

President and CEO, Radionetics Oncology

San Diego, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Investments

Tentarix Biotherapeutics

Series A

Total Funding: $85M

Pipeline Therapeutics

Series B

Total Funding: $110M

Taligen Therapeutics

Series B

Total Funding: $79M

Work Experience

Radionetics Oncology

2024

  • President and CEO

    2024

Tentarix Biotherapeutics, Inc.

2020 - 2024

  • President and CEO

    2020 - 2024

    Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage powerful synergistic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics.

Versant Ventures

2019 - 2024

  • Venture Partner

    2019 - 2024

Bird Rock Bio, Inc.

2011 - 2024

  • President and CEO

    2011 - 2024

Fate Therapeutics Inc

2008 - 2011

  • President and CEO

    2008 - 2011

Sanderling Ventures

2003 - 2008

  • Managing Director

    2003 - 2008

Senomyx, Inc.

1999 - 2003

  • President, CEO, Chairman and Founder

    1999 - 2003

Aurora BioSciences, Inc.

1996 - 1999

  • Senior Vice President, Corporate Development

    1996 - 1999